Package 50268-133-13

Brand: bupropion hydrochloride

Generic: bupropion hydrochloride
NDC Package

Package Facts

Identity

Package NDC 50268-133-13
Digits Only 5026813313
Product NDC 50268-133
Product ID 50268-133_2f9c516e-9c18-af30-e063-6394a90a4a70
Description

30 BLISTER PACK in 1 BOX (50268-133-13) / 1 TABLET, EXTENDED RELEASE in 1 BLISTER PACK (50268-133-11)

Marketing

Marketing Status
Marketed Since 2025-03-05
Brand bupropion hydrochloride
Generic bupropion hydrochloride
Sample Package No

Linked Drug Pages (1)

Bupropion Hydrochloride ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "2f9c516e-9c18-af30-e063-6394a90a4a70", "openfda": {"unii": ["ZG7E5POY8O"], "rxcui": ["993541", "993557"], "spl_set_id": ["2f9c5162-a6c5-e362-e063-6294a90a198d"], "manufacturer_name": ["AvPAK"]}, "finished": true, "packaging": [{"sample": false, "description": "30 BLISTER PACK in 1 BOX (50268-133-13)  / 1 TABLET, EXTENDED RELEASE in 1 BLISTER PACK (50268-133-11)", "package_ndc": "50268-133-13", "marketing_start_date": "20250305"}], "brand_name": "Bupropion Hydrochloride", "product_id": "50268-133_2f9c516e-9c18-af30-e063-6394a90a4a70", "dosage_form": "TABLET, EXTENDED RELEASE", "pharm_class": ["Aminoketone [EPC]", "Dopamine Uptake Inhibitors [MoA]", "Increased Dopamine Activity [PE]", "Increased Norepinephrine Activity [PE]", "Norepinephrine Uptake Inhibitors [MoA]"], "product_ndc": "50268-133", "generic_name": "Bupropion Hydrochloride", "labeler_name": "AvPAK", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Bupropion Hydrochloride", "active_ingredients": [{"name": "BUPROPION HYDROCHLORIDE", "strength": "150 mg/1"}], "application_number": "ANDA090693", "marketing_category": "ANDA", "marketing_start_date": "20250305", "listing_expiration_date": "20261231"}